A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer
Titel:
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer
Auteur:
Bang, Y.-J. Kang, Y.-K. Ng, M. Chung, H.C. Wainberg, Z.A. Gendreau, S. Chan, W.Y. Xu, N. Maslyar, D. Meng, R. Chau, I. Ajani, J.A.